Patient info Search Menu

Teriparatide Biotech 20mcg/80µL solution - PIL – patient leaflet, side effects, dosage

Updated:
Medicine strength:
20 micrograms
Contains active substance:

Patient leaflet - Teriparatide Biotech 20 micrograms/80 microlitres solution for injection in Pre-filled pen

1. What Teriparatide Biotech is and what it is used for

Teriparatide Biotech contains the active

substance teriparatide that is used to

make the bones stronger and to reduce

the risk of fractures by stimulating bone

formation.

Teriparatide Biotech is used to treat

osteoporosis in adults. Osteoporosis is a

disease that causes your bones to

become thin and fragile. This disease is

especially common in women after the

menopause, but it can also occur in

men. Osteoporosis is also common in

patients receiving corticosteroids.

2. What you need to know before you use Teriparatide Biotech

Do not use Teriparatide Biotech

  • if you are allergic to teriparatide or

    any of the other ingredients of this

    medicine (listed in section 6).

  • if you suffer from high calcium levels

    (pre-existing hypercalcaemia).

  • if you suffer from serious kidney

    problems.

  • if you have ever been diagnosed with

    bone cancer or other cancers that

    have spread (metastasised) to your

    bones.

Teriparatide Biotech 20 micrograms/ 80 microlitres solution for injection in pre-filled pen

Teriparatide

Package leaflet: Information for the user

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

    • if you have certain bone diseases. If you have a bone disease, tell your doctor.
    • if you have unexplained high levels of alkaline phosphatase in your blood, which means you might have Paget’s disease of bone (disease with abnormal bone changes). If you are not sure, ask your doctor.
    • if you have had radiation therapy involving your bones.
    • if you are pregnant or breast-feeding

Warning and precautions

Teriparatide Biotech may cause an increase in the amount of calcium in your blood or urine.

Talk to your doctor or pharmacist before or while using Teriparatide Biotech:

  • if you have continuing nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs there is too much calcium in your blood.
  • if you suffer from kidney stones or have a history of kidney stones.
  • if you suffer from kidney problems (moderate renal impairment).

Some patients get dizzy or get a fast heartbeat after the first few doses. For the first doses, inject Teriparatide Biotech where you can sit or lie down right away if you get dizzy.

The recommended treatment time of 24 months should not be exceeded.

Teriparatide Biotech should not be used in growing adults.

Children and adolescents

Teriparatide Biotech should not be used in children and adolescents (less than 18 years).

Other medicines and Teriparatide Biotech

Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines because occasionally they may interact (e.g. digoxin/digitalis, a medicine used to treat heart disease).

Pregnancy and breast-feeding

Do not use Teriparatide Biotech if you are pregnant or breast-feeding. If you are a woman of child-bearing potential, you should use effective methods of contraception during use of Teriparatide Biotech.

If you become pregnant, Teriparatide Biotech should be discontinued. Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Some patients may feel dizzy after injecting Teriparatide Biotech. If you feel dizzy you should not drive or use machines until you feel better.

Important information about some of the ingredients of Teriparatide Biotech

This medicine contains less than 1 mmol sodium (23 mg) per dose. This means that it is essentially “sodium-free”.

3. How to use Teriparatide Biotech

Always use this medicine exactly as your doctor has told you to. Check with your doctor or pharmacist if you are not sure.

The recommended dose is 20 micrograms given once daily by injection under the skin (subcutaneous injection) in the thigh or abdomen. To help you remember to take your medicine, inject it at about the same time each day.

Inject Teriparatide Biotech each day for as long as your doctor prescribes it for you. The total duration of treatment with Teriparatide Biotech should not exceed 24 months. You should not receive more than one treatment course of 24 months over your lifetime. Teriparatide Biotech can be injected at meal times.

Read the user manual booklet, which is included in the carton for instructions on how to use the Teriparatide Biotech pen

Injection needles are not included with the pen. Becton, Dickinson and

Company pen needles can be used.

You should take your Teriparatide Biotech injection shortly after you take the pen out of the refrigerator as described in the user manual. Put the pen back into the refrigerator immediately after you have used it. Use a new injection needle for each injection and dispose of it after each use. Never store your pen with the needle attached. Never share your Teriparatide Biotech pen with others.

Your doctor may advise you to take Teriparatide Biotech with calcium and vitamin D.

Your doctor will tell you how much you should take each day.

Teriparatide Biotech can be given with or without food.

If you use more of Teriparatide Biotech than you should

If, by mistake, you have used more Teriparatide Biotech than you should, contact your doctor or pharmacist. The effects of overdose that might be expected include nausea, vomiting, dizziness, and headache.

If you forget or cannot take Teriparatide Biotech at your usual time, take it as soon as possible on that day. Do not take a double dose to make up for a forgotten dose. Do not take more than one injection in the same day. Do not try to make up for a missed dose.

If you stop taking Teriparatide Biotech

If you are considering stopping Teriparatide Biotech treatment, please discuss this with your doctor. Your doctor will advise you and decide how long you should be treated with Teriparatide Biotech.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The most common side effects are pain in the limbs (frequency is very common: may affect more than 1 in 10 people) and feeling sick, headache and dizziness (frequency is common). If you become Biotech Pharma Limited Manufacturer

Teriparatide Biotech 20mcg/80µL solution - PIL

Formatting Criteria Teriparatide Biotech 20mcg/80µL solution

Single Page Dimensions

Number of Pages

Font Style

280 (W) x 270 (H)

Frutiger LT Std

15.5 pt

11 pt

9 pt

dizzy (light-headed) after your injection, you should sit or lie down until you feel better. If you do not feel better, you should call a doctor before you continue treatment. Cases of fainting have been reported in association with teriparatide use.

If you experience discomfort such as redness of the skin, pain, swelling, itching, bruising or minor bleeding around the area of the injection (frequency is common), this should clear up in a few days or weeks. Otherwise tell your doctor as soon as possible.

Some patients may have experienced allergic reactions soon after injection, consisting of breathlessness, swelling of the face, rash and chest pain (frequency is rare). In rare cases, serious and potentially life-threatening allergic reactions including anaphylaxis can occur.

Other side effects include:

Common: may affect up to 1 in 10 people

  • increase in blood cholesterol levels
  • depression
  • neuralgic pain in the leg
  • feeling faint
  • irregular heart beats
  • breathlessness
  • increased sweating
  • muscle cramps
  • loss of energy
  • tiredness
  • chest pain
  • low blood pressure
  • heartburn (painful or burning sensation just below the breast bone)
  • being sick (vomiting)
  • a hernia of the tube that carries food to your stomach
  • low haemoglobin or red blood cell count (anaemia)

Uncommon: may affect up to 1 in 100 people

  • increased heart rate
  • abnormal heart sound
  • shortness of breath
  • haemorrhoids (piles)
  • accidental loss or leakage of urine
  • increased need to pass water
  • weight increase
  • kidney stones
  • pain in the muscles and pain in the joints. Some patients have

    experienced severe back cramps or pain, which led to hospitalisation.

  • increase in blood calcium level
  • increase in blood uric acid level

    • increase in an enzyme called alkaline phosphatase.

Rare: may affect up to 1 in 1,000 people

  • reduced kidney function, including renal failure
  • swelling, mainly in the hands, feet and legs.

Reporting of side effects

If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Teriparatide Biotech

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and pen after EXP. The expiry date refers to the last day of that month.

Teriparatide Biotech should be stored in a refrigerator (2°C to 8°C) at all times. You can use the pen for up to 28 days after the first injection, as long as the pen is stored in a refrigerator (2°C to 8°C).

Do not freeze Teriparatide Biotech. Avoid placing the pens close to the ice compartment of the refrigerator to prevent freezing. Do not use the pen if it is, or has been, frozen.

Each pen should be properly disposed of after 28 days, even if it is not completely empty.

Teriparatide Biotech contains a clear and colorless solution. Do not use Teriparatide Biotech if solid particles appear or if the solution is cloudy or coloured.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Teriparatide Biotech contains

  • The active substance is teriparatide. Each ml of the solution for injection contains 250 micrograms of teriparatide.
  • The other ingredients are glacial acetic acid, sodium acetate, mannitol, metacresol, and water for injections. In addition, hydrochloric acid and/or sodium hydroxide solution may have been added for pH adjustment.

What Teriparatide Biotech looks like and contents of the pack

Teriparatide Biotech is a colorless and clear solution. It is supplied in a cartridge contained in a pre -filled disposable pen. Each pen contains 2.4 ml of solution enough for 28 doses. The pens are available in cartons containing 1 or 3 pens. Not all pack sizes may be available.

Marketing Authorisation Holder

Biotech Pharma Limited

Quantum House, Hobson,

Newcastle Upon Tyne, NE16 6EA, United Kingdom

Manufacturer

GP-PHARM, S.A.

Polígono Industrial Els Vinyets-Els Fogars, Sector 2, Carretera Comarcal C-244, Km 22 08777 Sant Quintí de Mediona Spain

This leaflet was last revised in 06/2025

Teriparatide Biotech Parts*

  1. 1. pen cap
  2. 2. cartridge with medicine
  3. 3. label
  4. 4. dose window
  5. 5. dose knob
  6. 6. dose activator
  7. 7. large outer cap
  8. 8. small inner cap
  9. 9. needle
  10. 10. seal foil

* Needles are not included.

Becton, Dickinson and Company pen needles can be used. Ask your doctor or pharmacist which needle gauge and length are best for you.

For your safety

Prevention of infectious diseases

  • Do not share your pen as this may risk the

    transmission of infectious diseases.

  • Use a new sterile needle for each injection.
  • Put used needles in a sharps container or a hard

    plastic container with a secure lid. Do not throw needles directly into your household waste.

Use of the pen

  • Check the pen label when taking the pen out of

    the refrigerator. Ensure that you use the right medicine.

  • Check the expiry date. Do not use the pen if it

    has expired.

  • Check the medicine. It must be clear, colourless

    and free of particles.

  • Do not transfer the medicine to a syringe. It

    must be administered using this pen only.

  • Do not use the pen for more than 28 injections.

    Diary on the back of these Instructions for Use. Calculate the date for the 28th injection by using a calendar and make a note of this date in the Injection Diary.

  • The pen is not recommended for use by the

    blind or visually impaired without help from a person who is trained in the proper use of the device.

Storage

  • Keep the pen in the refrigerator, preferably in

    the door compartment.

  • Keep the pen and needles out of the sight and

    reach of children.

Troubleshooting

  • If you have a problem with the injection, do not

    give a second injection on the same day.

  • Read the section “What to do if...” in these

    Instructions for Use.

  • Do not use the pen if it is damaged.
  • Only use the pen if the medicine is clear,

    colourless and free of particles.

  • If you cannot solve the problem by yourself

    or if you are uncertain, contact your doctor, pharmacist, nurse or carer.

Follow these instructions every time you prepare a

You only have to perform this step once. You do NOT need to repeat this step for the second, third or any further injections.

Attaching the needle

  1. 1. Remove the pen cap.
  2. 2.

    Take a new needle and remove the seal foil from

    the large outer cap.

  3. 3.

    Attach the needle with the large outer cap to

    the pen. Screw the large outer cap clockwise as far as it will go.

  4. 4.

    Remove the large outer cap from the needle and

    save it.

    Dialling the Dose

    1. 5.

      Turn the dose knob clockwise to the hard stop

      (until it cannot be rotated any further). Make in the dose window. The white mark and the window notch should be aligned.

    2. 6. Remove the small inner cap from the needle and throw away.
    3. 7. Hold the pen with the needle up. Push the dose activator as far as it will go (to the hard stop) and hold for 5 seconds. Collect the expelled liquid with a tissue.
    4. 8. Check that the display reads “0” and that this window, the white mark and the window notch are aligned, and the dose knob and pen body marks are aligned.

Removing the Needle

Remove the needle after preparation of the pen, to minimise the risk of infection.

  1. 9. Carefully push the needle into the large outer cap. Do not touch the needle.
  2. 10. Unscrew the needle by turning the large outer cap anti-clockwise and pull the needle from the pen.
  3. 11. Dispose of the needle (in the needle cap) in a sharps container or a hard plastic container with a secure lid as directed by your doctor or pharmacist (see “For your safety” above).

Keeping the Injection Diary

  1. 12. Note the current date and the date of the 28th injection in the Injection Diary on the back of these instructions for use.

further injections as described below.

Injecting the Pen

Prepare yourself for injection

  • Wash your hands before every injection.
  • Prepare the injection site (on the thigh or abdomen) as directed by your doctor, pharmacist or carer.

Use a new needle for every injection. A used needle poses a risk of infection.

Attaching the needle

  1. 1. Remove the pen cap.
  2. 2. Take a new needle and remove the seal foil from the needle cap.
  3. 3. Attach the needle with the large outer cap to the pen. Screw the large outer cap clockwise as far as it will go.
  4. 4. Remove the large outer cap from the needle and save it.

Pen User Manual

Instructions for use

Before you use your new pen, please read these instructions carefully. Follow the directions carefully when using the pen.

Your pen contains 28 days of medicine.

5 s

Teriparatide Biotech 20 micrograms/80 microlitres solution for injection in pre-filled pen

Biotech Pharma Limited Manufacturer

Formatting Criteria Teriparatide Biotech 20mcg/80µL solution

Single Page Dimensions

Number of Pages

Font Style

180 (W) x 560 (H)

Frutiger LT Std

18 pt

10 pt

9 pt

Dialling the Dose

  1. 5.

    Turn the dose knob clockwise to the hard stop

    (until it cannot be rotated any further). Make

    in the dose window. The white mark and the window notch should be aligned.

  2. 6.

    Remove the small inner cap from the needle and

    throw away.

  3. 7.

    Select an appropriate injection site and prepare

    your skin as recommended by your doctor. Gently hold a fold of skin from your thigh or

  4. 8.

    Insert the needle, preferably at a 90 degree

    angle at the prepared injection site. Push the dose activator as far as it will go (to the hard stop) and hold for 5 seconds. Count slowly to 5.

  5. 9. Pull out the needle from the skin.
  6. 10.

    Check that the display reads “0”and that this

    window, the white mark and the window notch are aligned, and the dose knob and pen body marks are aligned.

Removing the needle

Always remove the needle immediately after the pen has been used.

  1. 11.

    Carefully push the needle into the large outer

    cap. Do not touch the needle.

  2. 12.

    Unscrew the needle by turning the large outer cap

    anti-clockwise and pull the needle from the pen.

  3. 13.

    Dispose of the needle (in its large outer cap) in

    a sharps container or a hard plastic container with a secure lid, as directed by your doctor or pharmacist.

  4. 14. Re-attach the pen cap to the pen.

Storing the pen

  • Do not store the pen with a needle attached.

    Doing this may cause air bubbles to form in the medicine cartridge. Always close the pen with the pen cap.

  • Store the pen in the refrigerator, preferably

    in the door compartment. Do not store it next to the back wall of the refrigerator or in the freezer. The medicine becomes unusable if frozen.

  • If your pen has been left out of the refrigerator,

    do not throw the pen away. Put it back in the refrigerator and contact your doctor or pharmacist.

Disposing of the pen

  • Before throwing away the pen, be sure to

    remove the needle and attach the pen cap.

  • Throw away your pen and used needles in a

    sharps container or a hard plastic container with a secure lid, as directed by your doctor or pharmacist.

•

What to do if….

You can see an air bubble in the cartridge: You can continue to use your pen as usual.

medicine is expelled: Perform the steps as described in “Dialling the dose” again (page 5).

The dose activator is blocked or you think you may not have injected the full dose: Do not give a second injection the same day. Proceed with your regular injection the next day. Make sure you

“80” is fully visible and centred in the dose window with the white mark aligned in the window notch.

Injection Diary

Manufacturer

Date of last injection day 28

This user manual was last revised in 06/2025

5 s

Biotech Pharma Limited Manufacturer

Formatting Criteria Teriparatide Biotech 20mcg/80µL solution

Single Page Dimensions

Number of Pages

Font Style

180 (W) x 560 (H)

Frutiger LT Std

18 pt

10 pt

9 pt

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 50615/0002

Last revision stated in the text: June 2025 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Teriparatide Biotech 20 micrograms/80 microlitres solution for injection in Pre-filled pen

What these facts mean

Active substance? Teriparatide
Strength? 20 micrograms
Pharmaceutical form? Colorless, clear, isotonic solution with a pH of 3.8 to 4.5
Excipients? Acetic acid, glacial, Sodium acetate, anhydrous Mannitol, Metacresol, Hydrochloric acid (for pH adjustment), Sodium hydroxide (for pH adjustment), Water for injections
Shelf life? 24 months
Chemical, physical and microbiological in-use stability has been demonstrated for 28 days at 2-8°C. Once opened, the product may be stored for a maximum of 28 days at 2°C to 8°C. Other in-use storage times and conditions are the responsibility of the user.
Storage Store in a refrigerator (2°C – 8°C) at all times.
The pen should be returned to the refrigerator immediately after use. Do not freeze.
Do not store the injection device with the needle attached.
Drug group (ATC)? Calcium homeostasis, parathyroid hormones and analogues
  1. H Systemic hormonal preparations, excl. sex hormones and insulins
    1. H05 Calcium homeostasis
      1. H05A Parathyroid hormones and analogues
        1. H05AA Parathyroid hormones and analogues
          1. H05AA02 teriparatide
Marketing authorisation? PL 50615/0002 (first authorised 15 December 2025)
Marketing authorisation holder? Biotech Pharma Limited

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.